Industry: Chemical & Material
Published Date: 2025-02-15
Pages: 104 Pages
Report ld: 3967648
Request Sample
Customized Report
The global market for Voriconazole API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Voriconazole is a antifungal, It was first introduced in the US for the treatment of infections in immune deficiency patients.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
MARKET SEGMENTATION
REPORT SCOPE
This report aims to provide a comprehensive presentation of the global market for Voriconazole API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Voriconazole API.
The Voriconazole API market size, estimations, and forecasts are provided in terms of output/shipments (Ton) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Voriconazole API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Voriconazole API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Voriconazole API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Voriconazole API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Voriconazole API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Voriconazole API Market Overview
1.1 Product Definition
1.2 Voriconazole API by Type
1.2.1 Global Voriconazole API Market Value Growth Rate Analysis by Type: 2024 VS 2031
1.2.2 Oral Grade
1.2.3 Injection Grade
1.3 Voriconazole API by Application
1.3.1 Global Voriconazole API Market Value Growth Rate Analysis by Application: 2024 VS 2031
1.3.2 Voriconazole Tablets
1.3.3 Voriconazole Injection
1.4 Global Market Growth Prospects
1.4.1 Global Voriconazole API Production Value Estimates and Forecasts (2020-2031)
1.4.2 Global Voriconazole API Production Capacity Estimates and Forecasts (2020-2031)
1.4.3 Global Voriconazole API Production Estimates and Forecasts (2020-2031)
1.4.4 Global Voriconazole API Market Average Price Estimates and Forecasts (2020-2031)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Voriconazole API Production Market Share by Manufacturers (2020-2025)
2.2 Global Voriconazole API Production Value Market Share by Manufacturers (2020-2025)
2.3 Global Key Players of Voriconazole API, Industry Ranking, 2023 VS 2024
2.4 Global Voriconazole API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.5 Global Voriconazole API Average Price by Manufacturers (2020-2025)
2.6 Global Key Manufacturers of Voriconazole API, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Voriconazole API, Product Offered and Application
2.8 Global Key Manufacturers of Voriconazole API, Date of Enter into This Industry
2.9 Voriconazole API Market Competitive Situation and Trends
2.9.1 Voriconazole API Market Concentration Rate
2.9.2 Global 5 and 10 Largest Voriconazole API Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Voriconazole API Production by Region
3.1 Global Voriconazole API Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.2 Global Voriconazole API Production Value by Region (2020-2031)
3.2.1 Global Voriconazole API Production Value by Region (2020-2025)
3.2.2 Global Forecasted Production Value of Voriconazole API by Region (2026-2031)
3.3 Global Voriconazole API Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.4 Global Voriconazole API Production Volume by Region (2020-2031)
3.4.1 Global Voriconazole API Production by Region (2020-2025)
3.4.2 Global Forecasted Production of Voriconazole API by Region (2026-2031)
3.5 Global Voriconazole API Market Price Analysis by Region (2020-2025)
3.6 Global Voriconazole API Production and Value, Year-over-Year Growth
3.6.1 North America Voriconazole API Production Value Estimates and Forecasts (2020-2031)
3.6.2 Europe Voriconazole API Production Value Estimates and Forecasts (2020-2031)
3.6.3 China Voriconazole API Production Value Estimates and Forecasts (2020-2031)
3.6.4 Japan Voriconazole API Production Value Estimates and Forecasts (2020-2031)
4 Voriconazole API Consumption by Region
4.1 Global Voriconazole API Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
4.2 Global Voriconazole API Consumption by Region (2020-2031)
4.2.1 Global Voriconazole API Consumption by Region (2020-2025)
4.2.2 Global Voriconazole API Forecasted Consumption by Region (2026-2031)
4.3 North America
4.3.1 North America Voriconazole API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.3.2 North America Voriconazole API Consumption by Country (2020-2031)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Voriconazole API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.4.2 Europe Voriconazole API Consumption by Country (2020-2031)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Voriconazole API Consumption Growth Rate by Region: 2020 VS 2024 VS 2031
4.5.2 Asia Pacific Voriconazole API Consumption by Region (2020-2031)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Voriconazole API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.6.2 Latin America, Middle East & Africa Voriconazole API Consumption by Country (2020-2031)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Voriconazole API Production by Type (2020-2031)
5.1.1 Global Voriconazole API Production by Type (2020-2025)
5.1.2 Global Voriconazole API Production by Type (2026-2031)
5.1.3 Global Voriconazole API Production Market Share by Type (2020-2031)
5.2 Global Voriconazole API Production Value by Type (2020-2031)
5.2.1 Global Voriconazole API Production Value by Type (2020-2025)
5.2.2 Global Voriconazole API Production Value by Type (2026-2031)
5.2.3 Global Voriconazole API Production Value Market Share by Type (2020-2031)
5.3 Global Voriconazole API Price by Type (2020-2031)
6 Segment by Application
6.1 Global Voriconazole API Production by Application (2020-2031)
6.1.1 Global Voriconazole API Production by Application (2020-2025)
6.1.2 Global Voriconazole API Production by Application (2026-2031)
6.1.3 Global Voriconazole API Production Market Share by Application (2020-2031)
6.2 Global Voriconazole API Production Value by Application (2020-2031)
6.2.1 Global Voriconazole API Production Value by Application (2020-2025)
6.2.2 Global Voriconazole API Production Value by Application (2026-2031)
6.2.3 Global Voriconazole API Production Value Market Share by Application (2020-2031)
6.3 Global Voriconazole API Price by Application (2020-2031)
7 Key Companies Profiled
7.1 Dr. Reddy's Laboratories
7.1.1 Dr. Reddy's Laboratories Voriconazole API Company Information
7.1.2 Dr. Reddy's Laboratories Voriconazole API Product Portfolio
7.1.3 Dr. Reddy's Laboratories Voriconazole API Production, Value, Price and Gross Margin (2020-2025)
7.1.4 Dr. Reddy's Laboratories Main Business and Markets Served
7.1.5 Dr. Reddy's Laboratories Recent Developments/Updates
7.2 Murli Krishna Pharma
7.2.1 Murli Krishna Pharma Voriconazole API Company Information
7.2.2 Murli Krishna Pharma Voriconazole API Product Portfolio
7.2.3 Murli Krishna Pharma Voriconazole API Production, Value, Price and Gross Margin (2020-2025)
7.2.4 Murli Krishna Pharma Main Business and Markets Served
7.2.5 Murli Krishna Pharma Recent Developments/Updates
7.3 SGMR Pharmaceuticals
7.3.1 SGMR Pharmaceuticals Voriconazole API Company Information
7.3.2 SGMR Pharmaceuticals Voriconazole API Product Portfolio
7.3.3 SGMR Pharmaceuticals Voriconazole API Production, Value, Price and Gross Margin (2020-2025)
7.3.4 SGMR Pharmaceuticals Main Business and Markets Served
7.3.5 SGMR Pharmaceuticals Recent Developments/Updates
7.4 Medichem
7.4.1 Medichem Voriconazole API Company Information
7.4.2 Medichem Voriconazole API Product Portfolio
7.4.3 Medichem Voriconazole API Production, Value, Price and Gross Margin (2020-2025)
7.4.4 Medichem Main Business and Markets Served
7.4.5 Medichem Recent Developments/Updates
7.5 Hunan Huateng Pharmaceutical
7.5.1 Hunan Huateng Pharmaceutical Voriconazole API Company Information
7.5.2 Hunan Huateng Pharmaceutical Voriconazole API Product Portfolio
7.5.3 Hunan Huateng Pharmaceutical Voriconazole API Production, Value, Price and Gross Margin (2020-2025)
7.5.4 Hunan Huateng Pharmaceutical Main Business and Markets Served
7.5.5 Hunan Huateng Pharmaceutical Recent Developments/Updates
7.6 Glenmark Pharmaceuticals
7.6.1 Glenmark Pharmaceuticals Voriconazole API Company Information
7.6.2 Glenmark Pharmaceuticals Voriconazole API Product Portfolio
7.6.3 Glenmark Pharmaceuticals Voriconazole API Production, Value, Price and Gross Margin (2020-2025)
7.6.4 Glenmark Pharmaceuticals Main Business and Markets Served
7.6.5 Glenmark Pharmaceuticals Recent Developments/Updates
7.7 ST Pharma
7.7.1 ST Pharma Voriconazole API Company Information
7.7.2 ST Pharma Voriconazole API Product Portfolio
7.7.3 ST Pharma Voriconazole API Production, Value, Price and Gross Margin (2020-2025)
7.7.4 ST Pharma Main Business and Markets Served
7.7.5 ST Pharma Recent Developments/Updates
7.8 Synergene
7.8.1 Synergene Voriconazole API Company Information
7.8.2 Synergene Voriconazole API Product Portfolio
7.8.3 Synergene Voriconazole API Production, Value, Price and Gross Margin (2020-2025)
7.8.4 Synergene Main Business and Markets Served
7.8.5 Synergene Recent Developments/Updates
7.9 Rundu Pharmaceutical
7.9.1 Rundu Pharmaceutical Voriconazole API Company Information
7.9.2 Rundu Pharmaceutical Voriconazole API Product Portfolio
7.9.3 Rundu Pharmaceutical Voriconazole API Production, Value, Price and Gross Margin (2020-2025)
7.9.4 Rundu Pharmaceutical Main Business and Markets Served
7.9.5 Rundu Pharmaceutical Recent Developments/Updates
7.10 Zhejiang Huahai Pharmaceutical
7.10.1 Zhejiang Huahai Pharmaceutical Voriconazole API Company Information
7.10.2 Zhejiang Huahai Pharmaceutical Voriconazole API Product Portfolio
7.10.3 Zhejiang Huahai Pharmaceutical Voriconazole API Production, Value, Price and Gross Margin (2020-2025)
7.10.4 Zhejiang Huahai Pharmaceutical Main Business and Markets Served
7.10.5 Zhejiang Huahai Pharmaceutical Recent Developments/Updates
7.11 Neuland Lab
7.11.1 Neuland Lab Voriconazole API Company Information
7.11.2 Neuland Lab Voriconazole API Product Portfolio
7.11.3 Neuland Lab Voriconazole API Production, Value, Price and Gross Margin (2020-2025)
7.11.4 Neuland Lab Main Business and Markets Served
7.11.5 Neuland Lab Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Voriconazole API Industry Chain Analysis
8.2 Voriconazole API Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Voriconazole API Production Mode & Process Analysis
8.4 Voriconazole API Sales and Marketing
8.4.1 Voriconazole API Sales Channels
8.4.2 Voriconazole API Distributors
8.5 Voriconazole API Customer Analysis
9 Voriconazole API Market Dynamics
9.1 Voriconazole API Industry Trends
9.2 Voriconazole API Market Drivers
9.3 Voriconazole API Market Challenges
9.4 Voriconazole API Market Restraints
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Voriconazole API was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-07-14
Pages: 136
USD 3950.00
(Single User License)
The global Voriconazole API market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-21
Pages: 141
USD 2900.00
(Single User License)
The global Voriconazole API market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-21
Pages: 160
USD 4900.00
(Single User License)
The global Voriconazole API market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-15
Pages: 98
USD 4250.00
(Single User License)
The global market for Voriconazole API was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-15
Pages: 128
USD 3950.00
(Single User License)
Voriconazole is a antifungal, It was first introduced in the US for the treatment of infections in immune deficiency patients.
Published Date: 2024-04-12
Pages: 111
USD 4900.00
(Single User License)
Voriconazole is a antifungal, It was first introduced in the US for the treatment of infections in immune deficiency patients.
Published Date: 2024-01-17
Pages: 95
USD 2900.00
(Single User License)
Voriconazole is a antifungal, It was first introduced in the US for the treatment of infections in immune deficiency patients.
Published Date: 2024-01-09
Pages: 130
USD 3950.00
(Single User License)
The global market for Voriconazole API was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-07-14
Pages: 136
The global Voriconazole API market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-21
Pages: 141
The global Voriconazole API market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-21
Pages: 160
The global Voriconazole API market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-15
Pages: 98
The global market for Voriconazole API was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-15
Pages: 128
Voriconazole is a antifungal, It was first introduced in the US for the treatment of infections in immune deficiency patients.
Published: 2024-04-12
Pages: 111
Voriconazole is a antifungal, It was first introduced in the US for the treatment of infections in immune deficiency patients.
Published: 2024-01-17
Pages: 95
Voriconazole is a antifungal, It was first introduced in the US for the treatment of infections in immune deficiency patients.
Published: 2024-01-09
Pages: 130
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
REPORT SCOPE
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now